• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 1 - Diagnosis and Prognosis of Multiple Myeloma

Article

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma.

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma. He is joined by panel experts Jack Goldberg, MD, clinical professor of medicine and chief, Division of Hematology and Medical Oncology, Penn Presbyterian Medical Center; Shaji K. Kumar, MD, professor of medicine and consultant, Division of Hematology and Blood and Marrow Transplantation, Mayo Clinic; Gene Reeder, Rph, PhD, director, Managed Care Networks, Xcenda; and Anne Quinn Young, MPH, vice president of development and strategic partnerships, Multiple Myeloma Research Foundation (MMRF).

The panelists begin with a general discussion that focuses on the diagnosis and prognosis of multiple myeloma, including if early diagnosis is possible. Dr Kumar begins by analyzing whether there is evidence for familial myeloma.

Related Videos
CK Wang, MD, COTA
Eric Lander, MD
Eric Lander, MD
David Awad, PharmD, BCOP
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.